About Evitalife Pharma Private Limited
Data last updated:
Evitalife Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2012PTC229963. Its GSTIN is 07AACCE9211E1ZZ (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Rohit Kumar Barnwal and Subhash Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1869/A – 14 Basement Govindpuri Extension Kalkaji, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.68 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.26 Lakh (net margin 0.4%) and EBITDA of ₹8.13 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 73% over five years.
The company is associated with 1 brand: Evitalife. As per MCA filings, the company has open charges of ₹32 Lakh on record. Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website evitalifepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1869/A – 14 Basement Govindpuri Extension Kalkaji, New Delhi, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Evitalife Pharma Private Limited
The main business activity of Evitalife Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Evitalife Pharma Private Limited FY 2025 filings available
Evitalife Pharma Private Limited reported revenue of ₹5.68 Cr (down 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Evitalife Pharma Private Limited
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 73%. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Evitalife Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.13 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.26 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Evitalife Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Evitalife Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Evitalife Pharma Private Limited
Evitalife Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alester Pharma Private Limited | ₹5.7 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Chandigarh, India |
| Wenlay Medicare Private Limited | ₹5.7 Cr (FY 2024) | •••• | •••• | -74.0% | •••• | Mumbai, Maharashtra, India |
| Sowilo India Pharmaceuticals Private Limited | ₹5.69 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Delhi, India |
| Suyog Pharmaceuticals Private Limited | ₹5.69 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Thane, Maharashtra, India |
| Genova Biotechniques Private Limited | ₹5.69 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Evitalife Pharma Private Limited this company | ₹5.68 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | New Delhi, Delhi, India |
| Synit Drugs Pvt Ltd | ₹5.68 Cr (FY 2025) | •••• | •••• | 380.0% | •••• | Mumbai, Maharashtra, India |
| Altis Pharmaceuticals Private Limited | ₹5.68 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Tiruchirappalli, Tamil Nadu, India |
| Mico Petrochem Private Limited | ₹5.67 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Delhi, India |
| Aavish Drugs Private Limited | ₹5.67 Cr (FY 2024) | •••• | •••• | 934.0% | •••• | Hyderabad, Telangana, India |
| Wellgrow Pharma Private Limited | ₹5.66 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Evitalife Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Evitalife Pharma Private Limited
Evitalife Pharma Private Limited is audited by DEEPAK JHANWAR & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DEEPAK JHANWAR & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Evitalife Pharma Private Limited
Evitalife Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Kumar Barnwal Also directs: Evitalife Science Private Limited | Director | 14 Jan 2012 | 14 Years 8 Months | Current |
| Subhash Kumar Also directs: Evitalife Science Private Limited | Director | 13 Mar 2016 | 10 Years 6 Months | Current |
Ownership and Shareholding of Evitalife Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Evitalife Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2025 | Canara Bank | ₹7 Lakh | Open |
| 04 Aug 2021 | Canara Bank | ₹25 Lakh | Open |
Total charge records: 2 View all charges
Legal Cases of Evitalife Pharma Private Limited
Evitalife Pharma Private Limited has 3 court cases on record: 3 filed by Evitalife Pharma. All cases are pending. Status as checked on 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against Sankem Pharmaceuticals Private Limited | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against Shivansh Pharma | Pending |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Evitalife Pharma Private Limited
Evitalife Pharma operates one associated brand: Evitalife. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical franchise and manufacturing services are offered by Evitalife in India, focusing on quality products and business support. | evitalifepharma.com |
Employees and EPFO Compliance at Evitalife Pharma Private Limited
Employment history and EPFO contributions of people linked to Evitalife Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Evitalife Pharma Private Limited
Evitalife Pharma Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Subhash Kumar ceased to be Additional Director on 30 Sep 2016.
Credit Ratings, Litigation & Regulatory Alerts for Evitalife Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Evitalife Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Evitalife Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Evitalife Pharma Private Limited
Evitalife Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCE9211E1ZZ | Delhi | Active | 01 Jul 2017 |
| 02AACCE9211E1Z9 | Himachal Pradesh | Active | 29 Aug 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Evitalife Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evitalife Pharma Private Limited
Evitalife Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 January 2012 (14+ years old) and is registered under CIN U24233DL2012PTC229963.
Evitalife Pharma reported revenue of ₹5.68 Cr for FY 2024 (down 3% YoY).
Evitalife Pharma has 2 current directors:
- Rohit Kumar Barnwal - Director
- Subhash Kumar - Director
Evitalife Pharma reported a net profit of ₹2.26 Lakh (net margin 0.4%) and EBITDA of ₹8.13 Lakh (EBITDA margin 1.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Evitalife Pharma is 36% over three years and 73% over five years. In the latest year (FY 2024) revenue fell 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Evitalife Pharma is 07AACCE9211E1ZZ, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AACCE9211E1Z9 (Himachal Pradesh).
The CIN (Corporate Identification Number) of Evitalife Pharma is U24233DL2012PTC229963. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evitalife Pharma has 3 court cases on record: 3 filed by the company. 3 are pending.
Evitalife Pharma was incorporated on 14 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Evitalife Pharma by revenue are Alester Pharma Private Limited, Wenlay Medicare Private Limited, Sowilo India Pharmaceuticals Private Limited, Suyog Pharmaceuticals Private Limited, Genova Biotechniques Private Limited and 5 more, all in the Pharma industry (Formulations).
Subhash Kumar ceased to be Additional Director on 30 Sep 2016. Gaurav Kumar ceased to be Director on 15 Mar 2016. Subhash Kumar was appointed as Director on 13 Mar 2016. Evitalife Pharma has 4 board changes on record in total.